Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 250
  • Start Date: November 4, 2019
An Open Label, Multi-center Roll-over Study to Assess Long-term Effect in Pediatric Patients Treated With Tafinlar (Dabrafenib) and/or Mekinist (Trametinib)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Radiation, Drug
  • Participants: 58
  • Start Date: October 2, 2019
A Phase 2 Study of Dabrafenib (NSC# 763760) With Trametinib (NSC# 763093) After Local Irradiation in Newly-Diagnosed BRAF V600-Mutant High-Grade Glioma (HGG)
Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Radiation
  • Participants: 74
  • Start Date: August 28, 2019
A Phase II Study of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 115
  • Start Date: May 22, 2019
Defining Personal and Communal Aspects of Social Determinants of Health in Glioblastoma Population
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug, Biological
  • Participants: 108
  • Start Date: March 5, 2018
Molecularly-Driven Doublet Therapy for All Children With Refractory or Recurrent CNS Malignant Neoplasms and Young Adults With Refractory or Recurrent SHH Medulloblastoma
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 1500
  • Start Date: January 1, 2018
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Procedure, Drug
  • Participants: 108
  • Start Date: July 18, 2017
A Phase I Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2, a Genetically Engineered HSV-1 Virus, and Immunomodulation With Cyclophosphamide
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2
  • Intervention Type: Radiation
  • Participants: 100
  • Start Date: January 2011
A Phase II Study of Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation: An Assessment of Long Term Neurocognitive, Neuroendocrine Adn Ototoxicity Outcomes
Showing 1-9 of 9